Product Name: Dmoj/GI11104 (494-501)
Product Number: PE-01AAU95
Size: | 1 mg | | Price: | 58.00 |
| 5 mg | | $US | 126.00 |
| 20 mg | | | 230.00 |
Peptide Name: Dmoj/GI11104 (494-501)
Product Use: Peptide serves as a gene product mimotope peptide recognized by 8.3-like T cells.
Peptide Production Method: Solid-phase peptide synthesis
Peptide Origin: Drosophila mojavensis
Peptide Sequence: KYNKANVFL
Peptide Modifications N Terminus: Free amino
Peptide Modifications C Terminus: Amide
Peptide Molecular Mass Calculated: 1095.3 Da
Peptide Purity Percent after Synthesis and Purification: >95
Peptide Appearance: White powder
Peptide Form: Solid
Storage Conditions: -20°C
References[1] Lieberman SM, Takaki T, Han B, Santamaria P, Serreze DV, DiLorenzo TP. Individual nonobese diabetic mice exhibit unique patterns of CD8+ T cell reactivity to three islet antigens, including the newly identified widely expressed dystrophia myotonica kinase. J Immunol. 2004 Dec 1;173(11):6727-34. PMID: 15557165.[2] Trudeau JD, Kelly-Smith C, Verchere CB, Elliott JF, Dutz JP, Finegood DT, Santamaria P, Tan R. Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J Clin Invest. 2003 Jan;111(2):217-23. PMID: 12531877.[3] Amrani A, Serra P, Yamanouchi J, Trudeau JD, Tan R, Elliott JF, Santamaria P. Expansion of the antigenic repertoire of a single T cell receptor upon T cell activation. J Immunol. 2001 Jul 15;167(2):655-66. PMID: 11441068.